COVID LONG HAULT™ The FIRST Research-Driven Approach to Long COVID Recovery

Since 2020, the Covid Pandemic has impacted the world causing major pharmaceutical and industrial chemical companies to collectively engage in an eﬀort to stop the spread of the virus.

To date, over 670+ million people, globally, have "recovered" from COVID-19.

Doctors, hospitals, medical clinics and healthcare specialists are aware that certain patients, who have recovered from COVID-19, continue to experience lingering symptoms associated with the COVID-19 virus. These individuals are commonly referred to as “Covid Long Haulers”, (also known as "Long COVID", "Post COVID-19 Syndrome"). Reference link

Understanding Long COVID: A Global Health Challenge

Since the emergence of COVID-19, it’s estimated that over 400 million individuals worldwide have continued to experience lingering symptoms long after their initial COVID-19 infection has been resolved. This condition, known as Long COVID, affects vital physiological functions causing an array of challenges impacting many lives on a daily basis. These symptoms include chronic fatigue, headache, cognitive impairment, hair loss, shortness of breath, persistent cough, sleep disruption, cardiovascular irregularities, and others.

At COVID LONG HAULT CORP., we are committed to addressing this complex medical challenge through rigorous scientific research and innovative solutions. Our team of experts, led by Michael Klipper, a biochemist and formulation scientist, has spent over four years in research & development to understand the underlying mechanisms of Long COVID. The result: a novel nutraceutical that therapeutically supports healthy repair of the metabolic processes associated with the cause of Long COVID symptons.

Scientific Innovation: A Patented Nutraceutical Approach

On January 21, 2025, the United States Patent & Trademark Office granted a Patent to Michael Klipper for inventing a Composition and Method for Preventing Long-Term COVID-19 Morbidity. This novel invention marks a significant advancement in understanding and managing post-viral syndromes, including COVID-19.

Research-Backed Mechanisms of Action

The COVID LONG HAULT^™ formulation is designed is based on the validated biochemical principles and emerging clinical insights of the Patent. Our proprietary formulated supplement contains 28, “active” ingredients, including 12 trademarked Branded ingredients with scientifically validated proven benefits. This Premium Product is not a pharmaceutical drug, but a nutraceutical dietary supplement. Created to address the need of therapeutic support from Long COVID, this formula promotes healthy physiology associated with Longevity (Anti-Aging) and can be used as a daily dietary supplement.

COVID LONG HAULT™ provides the following properties:

Mitochondrial Resuscitation: Supports cellular energy production and combats post-viral fatigue.

NAD+ Replenishment: Enhances DNA repair mechanisms and metabolic function.

Anti-Inflammatory & Neuroprotective Effects: Mitigates oxidative stress and promotes neurological recovery.

Immune Modulation & Tissue Repair: Strengthens the body's defense mechanisms and accelerates systemic recovery.

The Growing Need for Solutions to Long COVID Symptons

Yale University School of Medicine has recently completed a study identifying that there are individuals experiencing Long COVID “like” symptoms resulting from Vaccination against contracting COVID-19. Known as Post-Vaccination Syndrome (PVS), suggest that individuals are experiencing the same persistent post-viral symptoms due to physiological disruptions, making the potential demand for COVID LONG HAULT^™an increasing effective intervention.

BUY NOW FOR 40% DISCOUNT

Expert Leadership & Scientific Advisory Board

Our research efforts are supported by a distinguished team of scientists and clinicians, including Dr. Lance B. Becker, a globally recognized expert in emergency medicine, mitochondrial science, and resuscitation research. His work on cellular recovery and metabolic dysfunction plays a pivotal role in guiding the scientific direction of COVID LONG HAULT^™.

Advancing the Future of Post-Viral Recovery

At COVID LONG HAULT CORP., our mission is to leverage cutting-edge scientific research to restore health and quality of life for individuals affected by Long COVID, and for individuals concerned about maintaining healthy metabolic functions to retard physiological aging. Through ongoing clinical evaluation, strategic collaborations, and continuous innovation, we aim to reshape the landscape of post-viral recovery with evidence-based, patient-centric solutions.

BECOME AN INVESTOR

DONATE*

Join us in taking steps toward creating a healthier world!

WANT TO PARTICIPATE!

clinicalstudy@covidlonghault.com

BECOME AN INVESTOR

investor@covidlonghault.com

DONATE

info@covidlonghault.com